These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 21211599)

  • 1. Patient characteristics and medical care costs associated with hypertriglyceridemia.
    Nichols GA; Arondekar B; Garrison LP
    Am J Cardiol; 2011 Jan; 107(2):225-9. PubMed ID: 21211599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hospital use and medical care costs up to 5 years after triglyceride lowering among patients with severe hypertriglyceridemia.
    Nichols GA; Arondekar B; Jacobson TA
    J Clin Lipidol; 2012; 6(5):443-9. PubMed ID: 23009780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between fibrate use, change in high-density lipoprotein cholesterol, and the risk of cardiovascular disease: a retrospective chart review involving up to 8 years of follow-up.
    Nichols GA; Koro CE; Chan W; Bowlin SJ; Sprecher DL
    Clin Ther; 2006 Feb; 28(2):243-50. PubMed ID: 16678645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin.
    Breuer HW
    Curr Med Res Opin; 2001; 17(1):60-73. PubMed ID: 11464448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determining triglyceride reductions needed for clinical impact in severe hypertriglyceridemia.
    Christian JB; Arondekar B; Buysman EK; Jacobson TA; Snipes RG; Horwitz RI
    Am J Med; 2014 Jan; 127(1):36-44.e1. PubMed ID: 24384100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and economic benefits observed when follow-up triglyceride levels are less than 500 mg/dL in patients with severe hypertriglyceridemia.
    Christian JB; Arondekar B; Buysman EK; Johnson SL; Seeger JD; Jacobson TA
    J Clin Lipidol; 2012; 6(5):450-61. PubMed ID: 23009781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia.
    Sorensen SV; Frick KD; Wade A; Simko R; Burge R
    Clin Ther; 2009 Apr; 31(4):862-79. PubMed ID: 19446159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and economic outcomes in a real-world population of patients with elevated triglyceride levels.
    Toth PP; Grabner M; Ramey N; Higuchi K
    Atherosclerosis; 2014 Dec; 237(2):790-7. PubMed ID: 25463122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
    Goel PK; Bharti BB; Pandey CM; Singh U; Tewari S; Kapoor A; Garg N; Sinha N
    Indian Heart J; 2003; 55(3):234-40. PubMed ID: 14560932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between isolated hypercholesterolemia, isolated hypertriglyceridemia and coronary artery disease in south Indian type 2 diabetic patients.
    Rajmohan L; Deepa R; Mohan A; Mohan V
    Indian Heart J; 2000; 52(4):400-6. PubMed ID: 11084779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostics of moderate and high hypertriglyceridemia in patients in polyclinic practice: primary and secondary lipid metabolic disorders].
    Rozhkova TA; Titov VN; Ameliushkina VA; Iarovaia EB; Malyshev PP; Meshkov AN; Kukharchuk VV
    Ter Arkh; 2010; 82(4):10-7. PubMed ID: 20481208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Combination Cholesterol-Lowering Therapy and Triglyceride-Lowering Therapy on Medical Costs in Patients With Type 2 Diabetes Mellitus.
    Nichols GA; Reynolds K; Olufade T; Kimes TM; O'Keeffe-Rosetti M; Sapp DS; Anzalone D; Fortmann SP
    Am J Cardiol; 2017 Feb; 119(3):410-415. PubMed ID: 27890243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of increasing doses of atorvastatin on the atherogenic lipid subclasses commonly associated with hypertriglyceridemia.
    Karalis DG; Ishisaka DY; Luo D; Ntanios F; Wun CC
    Am J Cardiol; 2007 Aug; 100(3):445-9. PubMed ID: 17659926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of serum HDL-C level in a Tehran urban population: the Tehran Lipid and Glucose Study.
    Azizi F; Raiszadeh F; Salehi P; Rahmani M; Emami H; Ghanbarian A; Hajipour R
    Nutr Metab Cardiovasc Dis; 2002 Apr; 12(2):80-9. PubMed ID: 12189907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescription omega-3 fatty acid as an adjunct to fenofibrate therapy in hypertriglyceridemic subjects.
    Roth EM; Bays HE; Forker AD; Maki KC; Carter R; Doyle RT; Stein EA
    J Cardiovasc Pharmacol; 2009 Sep; 54(3):196-203. PubMed ID: 19597368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical care costs among patients with established cardiovascular disease.
    Nichols GA; Bell TJ; Pedula KL; O'Keeffe-Rosetti M
    Am J Manag Care; 2010 Mar; 16(3):e86-e93. PubMed ID: 20205493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk-factor clustering and cardiovascular disease risk in hypertensive patients.
    Weycker D; Nichols GA; O'Keeffe-Rosetti M; Edelsberg J; Khan ZM; Kaura S; Oster G
    Am J Hypertens; 2007 Jun; 20(6):599-607. PubMed ID: 17531915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated Triglyceride Level Is Independently Associated With Increased All-Cause Mortality in Patients With Established Coronary Heart Disease: Twenty-Two-Year Follow-Up of the Bezafibrate Infarction Prevention Study and Registry.
    Klempfner R; Erez A; Sagit BZ; Goldenberg I; Fisman E; Kopel E; Shlomo N; Israel A; Tenenbaum A
    Circ Cardiovasc Qual Outcomes; 2016 Mar; 9(2):100-8. PubMed ID: 26957517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Medical Care Utilization and Costs Among Patients With Statin-Controlled Low-Density Lipoprotein Cholesterol With Versus Without Hypertriglyceridemia.
    Nichols GA; Philip S; Reynolds K; Granowitz CB; O'Keeffe-Rosetti M; Fazio S
    Am J Cardiol; 2018 Oct; 122(7):1128-1132. PubMed ID: 30086877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Elevated Triglycerides With Increased Cardiovascular Risk and Direct Costs in Statin-Treated Patients.
    Toth PP; Philip S; Hull M; Granowitz C
    Mayo Clin Proc; 2019 Sep; 94(9):1670-1680. PubMed ID: 31405751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.